This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
L-Selectin (CD62L) Recombinant Rat Monoclonal Antibody (MEL-14)
catalog :
MA5-48008
quantity :
200 ug
price :
US 520.00
clonality :
recombinant
host :
rat
conjugate :
nonconjugated
clone name :
MEL-14
The same clone is also sold as:
The same clone is also sold as:
- Bio-Rad: MCA1259PE
- Wuhan Fine Biotech Co.,Ltd.: FITC-30084, PE-30084, PC7-30084, APC-30084
- OriGene: CL032RX, CL032F, CL032BX, CL032P, CL032B, CL032FX, CL032R, CL032A
- Exbio: 11-626-C100, 1F-626-C100, 12-626-C100
- ichorbio: ICH1060
- BD Biosciences: 553150, 560507, 561917, 553151, 560513, 560517, 563252, 553152, 553147, 561919, 560516, 562404, 553149, 561918, 553148, 564109, 560514, 562910
- BioLegend: 104457, 104423, 104419, 104447, 104411, 104429, 104410, 104450, 104441, 104438, 104463, 104428, 104449, 104427, 104437, 104418, 104431, 104448, 104417, 104460, 104461, 104406, 285089, 104405, 104440, 104403, 104412, 104407, 104424, 104421, 104465, 104435, 104459, 104408, 104402, 104462, 104453, 104451, 104404, 104420, 104455, 104433, 104426, 104464, 104445, 104436, 104430, 104458, 104443, 104432
- Abcam: ab119834
- Rockland Immunochemicals: 200-502-N87, 200-526-N87, 200-508-N87
- Bio X Cell: BE0021-100MG, BE0021-5MG, BE0021-25MG, BE0021-1MG, BE0021-50MG
reactivity :
mouse
application :
immunohistochemistry, immunoprecipitation, flow cytometry
product information
Product Type :
Antibody
Product Name :
L-Selectin (CD62L) Recombinant Rat Monoclonal Antibody (MEL-14)
Catalog # :
MA5-48008
Quantity :
200 ug
Price :
US 520.00
Clonality :
Recombinant Monoclonal
Purity :
protein A
Host :
Rat
Reactivity :
Mouse
Applications :
Flow Cytometry: Assay-dependent, Immunohistochemistry: Assay-dependent, Immunoprecipitation: Assay-dependent, Inhibition Assays: Assay-dependent
Species :
Mouse
Clone :
MEL-14
Isotype :
IgG2a, kappa
Storage :
Store at 4 C short term. For long term storage, store at -20 C, avoiding freeze/thaw cycles.
Description :
The human CD62L is a 74-95 kDa glycoprotein member of the selectin family of adhesion receptors. L-Selectin is comprised of an aminoterminal C-type lectin binding domain, an epidermal growth factor-like domain, two short consensus repeat (SCR) sequences homologous to those found in complement binding proteins, a short spacer region, a transmembrane region and a short cytoplasmic region. Human CD62L (L-Selectin) is constitutively expressed on all classes of leukocytes including lymphocytes (except a substantial population of memory T cells), monocytes and polymorphonuclear cells.
Immunogen :
C3H/eb mouse B lymphoma 38C-13.
Format :
Liquid
Applications w/Dilutions :
Flow Cytometry: Assay-dependent, Immunohistochemistry: Assay-dependent, Immunoprecipitation: Assay-dependent, Inhibition Assays: Assay-dependent
Aliases :
A.11; AI528707; CD62 antigen-like family member L; CD62L; gp90-MEL; hLHRc; LAM1; LAM-1; LECAM1; LECAM-1; LEU8; Leu-8; Leukocyte adhesion molecule 1; leukocyte surface antigen Leu-8; Leukocyte-endothelial cell adhesion molecule 1; LNHR; LSEL; L-selectin; Ly22; Ly-22; LYAM1; Lyam-1; Ly-m22; Lymph node homing receptor; lymphocyte adhesion molecule 1; lymphocyte antigen 22; Lymphocyte surface MEL-14 antigen; pln homing receptor; PLNHR; SELE; selectin E (endothelial adhesion molecule 1); selectin L; selectin L (lymphocyte adhesion molecule 1); selectin, lymphocyte; Sell; TQ1
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments